Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Carter

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Plos One|September 12, 2013
Induction of porcine host defense peptide gene expression by short-chain fatty acids and their analogsXiangfang Zeng, Lakshmi T Sunkara, Weiyu Jiang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 20, 2024
Gut Microbiome and Osteoarthritis: Insights From the Naturally Occurring Canine Model of OsteoarthritisChristina Stevens, Samantha Norris, Liubov Arbeeva, et al.
Psychological Methods|October 7, 2024
Harvesting heterogeneity: Selective expertise versus machine learningRumen Iliev, Alex Filipowicz, Francine Chen, et al.
The Journal of Physiology|January 8, 2015
An investigation into the relationship between age and physiological function in highly active older adultsRoss D Pollock, Scott Carter, Cristiana P Velloso, et al.
Oncotarget|May 12, 2016
A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicineEliezer M Van Allen, Dan Robinson, Colm Morrissey, et al.
Journal of the American College of Radiology : JACR|February 5, 2013
ACR Appropriateness Criteria prostate cancer--pretreatment detection, staging, and surveillanceSteven C Eberhardt, Scott Carter, David D Casalino, et al.
Future Oncology (London, England)|April 10, 2020
Temozolomide in secondary prevention of HER2-positive breast cancer brain metastasesAlexandra S Zimmer, Seth M Steinberg, Dee Dee Smart, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|August 23, 2022
Bronchopulmonary dysplasia and neurobehavioural outcomes at birth and 2 years in infants born before 30 weeksMonika Martin, Lynne Smith, Julie A Hofheimer, et al.
Lancet Regional Health. Americas|March 14, 2025
Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in BrazilMarco Antonio Moreira Puga, Roberto Dias de Oliveira, Patricia Vieira da Silva, et al.
BMJ Public Health|July 7, 2025
Antispike IgG antibody decay after immunisation with fractional versus full booster doses of COVID-19 vaccines: a 6-month longitudinal analysis of the FRACT-COV trial in BrazilJuliana Barros Verruck, Marco Antonio Moreira Puga, Roberto Dias de Oliveira, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Plos One|September 12, 2013
Induction of porcine host defense peptide gene expression by short-chain fatty acids and their analogsXiangfang Zeng, Lakshmi T Sunkara, Weiyu Jiang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 20, 2024
Gut Microbiome and Osteoarthritis: Insights From the Naturally Occurring Canine Model of OsteoarthritisChristina Stevens, Samantha Norris, Liubov Arbeeva, et al.
Psychological Methods|October 7, 2024
Harvesting heterogeneity: Selective expertise versus machine learningRumen Iliev, Alex Filipowicz, Francine Chen, et al.
The Journal of Physiology|January 8, 2015
An investigation into the relationship between age and physiological function in highly active older adultsRoss D Pollock, Scott Carter, Cristiana P Velloso, et al.
Oncotarget|May 12, 2016
A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicineEliezer M Van Allen, Dan Robinson, Colm Morrissey, et al.
Journal of the American College of Radiology : JACR|February 5, 2013
ACR Appropriateness Criteria prostate cancer--pretreatment detection, staging, and surveillanceSteven C Eberhardt, Scott Carter, David D Casalino, et al.
Future Oncology (London, England)|April 10, 2020
Temozolomide in secondary prevention of HER2-positive breast cancer brain metastasesAlexandra S Zimmer, Seth M Steinberg, Dee Dee Smart, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|August 23, 2022
Bronchopulmonary dysplasia and neurobehavioural outcomes at birth and 2 years in infants born before 30 weeksMonika Martin, Lynne Smith, Julie A Hofheimer, et al.
Lancet Regional Health. Americas|March 14, 2025
Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in BrazilMarco Antonio Moreira Puga, Roberto Dias de Oliveira, Patricia Vieira da Silva, et al.
BMJ Public Health|July 7, 2025
Antispike IgG antibody decay after immunisation with fractional versus full booster doses of COVID-19 vaccines: a 6-month longitudinal analysis of the FRACT-COV trial in BrazilJuliana Barros Verruck, Marco Antonio Moreira Puga, Roberto Dias de Oliveira, et al.
Pageof 3